-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US30234E2037 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Target Price | 6.275 |
|---|---|
| Beta | 2.58 |
| Market Cap | 52M |
| PE Ratio | None |
| Dividend Yield | None |
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It also develops the Optejet User Filled Device for horizontal, microdose spray delivery of ophthalmic liquids, such as artificial tears and lens rewetting products, as well as related topical ocular therapies. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Laguna Hills, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HYPD using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026